Financing and insurance provisions should be described where if not addressed in a separate agreement?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Financing and insurance provisions should be described where if not addressed in a separate agreement?

Explanation:
Financing and insurance terms must be clearly documented where the trial agreement is formed. If these provisions aren’t laid out in a separate financing agreement, they should be specified in the contract or agreement between the sponsor and the site. This ensures that who pays for what, what insurance coverage is required, indemnification, and related responsibilities are clearly defined and legally binding, reducing ambiguity and helping ensure compliance with GCP and protection of participants. Not documenting them would create ambiguity and potential liability gaps. Relying only on a separate financing agreement ignores the scenario described, where such a separate document isn’t used. And leaving financing and insurance to the investigator’s determination would undermine sponsor and institutional accountability for financial risk and participant protection.

Financing and insurance terms must be clearly documented where the trial agreement is formed. If these provisions aren’t laid out in a separate financing agreement, they should be specified in the contract or agreement between the sponsor and the site. This ensures that who pays for what, what insurance coverage is required, indemnification, and related responsibilities are clearly defined and legally binding, reducing ambiguity and helping ensure compliance with GCP and protection of participants.

Not documenting them would create ambiguity and potential liability gaps. Relying only on a separate financing agreement ignores the scenario described, where such a separate document isn’t used. And leaving financing and insurance to the investigator’s determination would undermine sponsor and institutional accountability for financial risk and participant protection.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy